Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.

ShujaaEdin, Hareth Y; Al-Haj, Nagi A; Rasedee, Abdullah; Alitheen, Noorjahan Banu; Kadir, Arifah Abdul; How, Chee Wun; Rahman, Heshu Sulaiman; Abdullah, Al-Shwyeh Hussah.

Afiliação

ShujaaEdin HY; Institute of Bioscience, Universiti Putra Malaysia, Malaysia.
Al-Haj NA; Faculty of Medicine and Health Sciences, Sana'a University, Yemen.
Rasedee A; Faculty of Veterinary Medicine, Universiti Putra Malaysia, Malaysia.
Alitheen NB; Faculty of Biotechnology and Biomolecular Sciences, University Putra Malaysia, Malaysia.
Kadir AA; Faculty of Veterinary Medicine, Universiti Putra Malaysia, Malaysia.
How CW; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Rahman HS; College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
Abdullah AH; College of Science, Imam Abdul Rahman bin Faisal University, Saudi Arabia.

Saudi J Biol Sci ; 28(4): 2549-2557, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33935571

Palavras-chave

2-dimensional MCF-7 cell culture; 3-dimensional MCF-7 cell culture; AO/PI, acridine orange/propidium iodide staining; FBS, fetal bovine serum; MCF-7 cell; MTT, (4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay; NRR, neutral red retention; Recombinant human erythropoietin; TBE, trypan blue exclusion; ULAT, ultra-low adhesion technique; rHuEPO, recombinant human erythropoietin

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article